Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00IXM
|
|||
Former ID |
DIB001295
|
|||
Drug Name |
DR-3001
|
|||
Indication | Urinary incontinence [ICD-11: MF50.2; ICD-9: 788.3] | Phase 3 | [1] | |
Company |
Barr Laboratories
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT00685113) A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.